These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9871561)

  • 1. Synthesis and in vitro cancer cell growth inhibitory activity of monocyclic model compounds containing spongistatin triene side-chains.
    Smith AB; Lin Q; Pettit GR; Chapuis JC; Schmidt JM
    Bioorg Med Chem Lett; 1998 Mar; 8(6):567-8. PubMed ID: 9871561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of a spongistatin AB-spiroketal analogue.
    Smith AB; Corbett RM; Pettit GR; Chapuis JC; Schmidt JM; Hamel E; Jung MK
    Bioorg Med Chem Lett; 2002 Aug; 12(15):2039-42. PubMed ID: 12113837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of spongistatin/altohyrtin analogues: E-ring dehydration and C46 side-chain truncation.
    Paterson I; Aceña JL; Bach J; Chen DY; Coster MJ
    Chem Commun (Camb); 2003 Feb; (4):462-3. PubMed ID: 12638950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An aldol approach to the synthesis of the EF fragment of spongistatin 1.
    Crimmins MT; Katz JD; McAtee LC; Tabet EA; Kirincich SJ
    Org Lett; 2001 Mar; 3(6):949-52. PubMed ID: 11263923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based design of a novel synthetic spiroketal pyran as a pharmacophore for the marine natural product spongistatin 1.
    Uckun FM; Mao C; Vassilev AO; Huang H; Jan ST
    Bioorg Med Chem Lett; 2000 Mar; 10(6):541-5. PubMed ID: 10741549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The spongistatins, potently cytotoxic inhibitors of tubulin polymerization, bind in a distinct region of the vinca domain.
    Bai R; Taylor GF; Cichacz ZA; Herald CL; Kepler JA; Pettit GR; Hamel E
    Biochemistry; 1995 Aug; 34(30):9714-21. PubMed ID: 7626642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological activity of lactones en route to Altohyrtin A.
    Hermitage SA; Murphy A; Roberts SM
    Bioorg Med Chem Lett; 1998 Jul; 8(13):1635-8. PubMed ID: 9873404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total synthesis of (+)-spongistatin 1. An effective second-generation construction of an advanced EF Wittig salt, fragment union, and final elaboration.
    Smith AB; Zhu W; Shirakami S; Sfouggatakis C; Doughty VA; Bennett CS; Sakamoto Y
    Org Lett; 2003 Mar; 5(5):761-4. PubMed ID: 12605509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asymmetric total synthesis of spongistatins 1 and 2.
    Crimmins MT; Katz JD; Washburn DG; Allwein SP; McAtee LF
    J Am Chem Soc; 2002 May; 124(20):5661-3. PubMed ID: 12010038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spongistatin synthetic studies. An efficient, second-generation construction of an advanced ABCD intermediate.
    Smith AB; Doughty VA; Sfouggatakis C; Bennett CS; Koyanagi J; Takeuchi M
    Org Lett; 2002 Mar; 4(5):783-6. PubMed ID: 11869127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of the C(2)-C(13) fragment (the A-B spiroketal unit) of spongistatin 1 (altohyrtin A): use of a common intermediate for the synthesis of both spongistatin spiroketals.
    Holson EB; Roush WR
    Org Lett; 2002 Oct; 4(21):3723-5. PubMed ID: 12375928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of the C29-C44 portion of spongistatin 1 (altohyrtin A).
    Wallace GA; Scott RW; Heathcock CH
    J Org Chem; 2000 Jun; 65(13):4145-52. PubMed ID: 10866633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic macrolides that inhibit breast cancer cell migration in vitro.
    Metaferia BB; Chen L; Baker HL; Huang XY; Bewley CA
    J Am Chem Soc; 2007 Mar; 129(9):2434-5. PubMed ID: 17295491
    [No Abstract]   [Full Text] [Related]  

  • 14. Total synthesis as a resource in the discovery of potentially valuable antitumor agents: cycloproparadicicol.
    Yamamoto K; Garbaccio RM; Stachel SJ; Solit DB; Chiosis G; Rosen N; Danishefsky SJ
    Angew Chem Int Ed Engl; 2003 Mar; 42(11):1280-4. PubMed ID: 12645064
    [No Abstract]   [Full Text] [Related]  

  • 15. Structure-activity relationships of halichondrin B analogues: modifications at C.30-C.38.
    Wang Y; Habgood GJ; Christ WJ; Kishi Y; Littlefield BA; Yu MJ
    Bioorg Med Chem Lett; 2000 May; 10(10):1029-32. PubMed ID: 10843209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of the C16-C28 spiroketal subunit of spongistatin 1 (altohyrtin A): the pyrone approach.
    Crimmins MT; Katz JD
    Org Lett; 2000 Apr; 2(7):957-60. PubMed ID: 10768196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of the C(29)-C(45) bis-pyran subunit (E-F) of spongistatin 1 (Altohyrtin A).
    Micalizio GC; Pinchuk AN; Roush WR
    J Org Chem; 2000 Dec; 65(25):8730-6. PubMed ID: 11112596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diastereoselective synthesis of the C(17)-C(28) fragment (the C-D spiroketal unit) of spongistatin 1 (altohyrtin A) via a kinetically controlled iodo-spiroketalization reaction.
    Holson EB; Roush WR
    Org Lett; 2002 Oct; 4(21):3719-22. PubMed ID: 12375927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spongistatin 1, a highly cytotoxic, sponge-derived, marine natural product that inhibits mitosis, microtubule assembly, and the binding of vinblastine to tubulin.
    Bai R; Cichacz ZA; Herald CL; Pettit GR; Hamel E
    Mol Pharmacol; 1993 Oct; 44(4):757-66. PubMed ID: 8232226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The stereocontrolled total synthesis of altohyrtin A/spongistatin 1: fragment couplings, completion of the synthesis, analogue generation and biological evaluation.
    Paterson I; Chen DY; Coster MJ; Aceña JL; Bach J; Wallace DJ
    Org Biomol Chem; 2005 Jul; 3(13):2431-40. PubMed ID: 15976860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.